The Taraba Primary Health Care Development Agency has begun a 3-day orientation for 250 newly recruited ad hoc Community Health Outreach Workers (CHEWs) under the GAVI-HSS programme.
Declaring the Jalingo training open on Friday, Health Commissioner Dr. Innocent Vakkai congratulated the participants and asked them to consider themselves lucky for the privilege of serving as CHEW in the programme.
Represented by the Executive Secretary of the state Primary Health Care Development Agency, Dr. Aminu Hassan, the commissioner asked them to be good ambassadors for the agency and be guided by the standing order of community health professionals. in carrying out their responsibilities.
He explained that the training was to familiarize participants with the agency's activities and programs in order to reposition them for effective and efficient delivery of primary health care services throughout the state.
The commissioner said the training was the culmination of a process that began three years ago under the agency's supervision in collaboration with the Global Alliance for Vaccines and Immunization (GAVI).
He explained that the exercise involved a rigorous process of analysis of the situation, justification of support for the program, development and review of the work plan, among others.
“These processes eventually led to the signing of a Memorandum of Understanding (MoU) between the Taraba State Government led by the Honorable Governor, Alhaji Haruna Manu, and GAVI in February 2022.
“Taraba state is one of eight states selected for the GAVI support fund.
"The support that has been delivered through UNICEF is aimed at Strengthening the Health System (HSS) in the state," he said.
The agency's executive secretary, Dr. Aminu Hassan, in his own separate statement, highlighted the passion shown by his team and the effort put in by the government to ensure that a functioning primary health system in the state is consistently delivering results.
He revealed that, among others, the success stories recorded were the recruitment and ongoing training of qualified ad hoc CHEW who are being redesigned to boost the health system in the state through the GAVI support fund.
It revealed that CHEWs were drawn from all 16 local government areas in the state.
Aminu attributed the agency's achievements and success stories to sustained support from Governor Darius Ishaku.
The Nigerian News Agency reports that other organizations, including NPHCDA, WHO and UNICEF, that are partnering with the agency gave messages of goodwill and assured their continued support for the state in achieving the Universal Health Care delivery target.
The European Union is committing an additional €450,000 of humanitarian funds to support the fight against life-threatening measles outbreaks in Somalia. With measles cases on the rise in 2021-2022, this funding will support the CAAFIMAD consortium, funded by the EU and led by Action Against Hunger (ACF), to contribute to the reduction of measles morbidity and mortality. CAAFIMAD partners will work through a combination of district-wide mass vaccination for children under 15, medical management of complicated cases, vitamin A supplementation for children under 5, and screening for malnutrition followed by appropriate management. This intervention builds on efforts made this year in support of measles vaccination in Somalia, under the leadership of the Ministry of Health, along with other humanitarian health partners.
Currently, vaccination coverage among displaced children under the age of 15 is extremely low, as displaced households come from hard-to-reach areas with limited or no humanitarian assistance, including basic health services.
This intervention will expand outbreak control efforts in the most affected districts of Galkacyo South, Baidoa, Afgoye and Bardhere in south-central Somalia.
“Today, hundreds of thousands of Somalis, especially women and children, are facing famine. Thousands will die preventable deaths in the absence of interventions like this expanded measles vaccination and treatment effort. Severely malnourished children are nine times more likely to die from measles and other preventable diseases; therefore, the immediate availability of treatment is of paramount importance,” said Javier Rio Navarro, Head of the EU Humanitarian Aid Office in Somalia.
ECHO's partner, the World Health Organization, will also support this effort by providing the necessary material to strengthen laboratory and surveillance capacities. UNICEF continues to support measles vaccination and other critical vaccination campaigns in Somalia by providing vaccines through the Global Alliance for Vaccination, GAVI.
Mozambique kicked off the third round of vaccination against wild poliovirus type 1 today, as southern African countries launch a new campaign to protect all children under 5 and stop the spread of the debilitating virus. Neighboring Malawi, Tanzania and Zambia will also embark on the third phase of mass vaccination campaigns in the coming weeks.
The four countries have administered around 36 million doses of vaccine in the first two rounds. The mass vaccination campaigns were launched after an outbreak in Malawi - the country's first cases of wild poliovirus in 30 years. Mozambique also detected a case in May. Only two cases of wild poliovirus have been confirmed in this region in 2022.
The cases detected in the two countries do not alter Africa's certification free of wild poliovirus - an achievement declared in 2020 - because the strain of the virus is not indigenous. Laboratory analyzes linked strains detected in Malawi and Mozambique to a strain circulating in Pakistan's Sindh province in 2019.
Zimbabwe will join the vaccination campaign for the third and fourth rounds. Although the country does not share a border with Malawi, frequent cross-border movements increase the risk of an outbreak of wild polio. Zimbabwe will carry out two more rounds later this year to ensure full vaccination coverage for all children under 5 years of age.
“Every effort is being made to vaccinate all eligible children. This is a dangerous disease that has no cure, but full vaccination can prevent paralysis,” said Dr. Modjirom Ndoutabe, Polio Program Coordinator at the World Health Organization (WHO) Regional Office for Africa. “We are supporting these five countries to carry out effective and quality vaccination campaigns that will protect children and eradicate the virus.”
Multiple vaccination rounds aim to ensure that all children under 5 years of age are fully vaccinated against poliovirus in countries at risk. To achieve this, WHO and its partners, including UNICEF, the Bill & Melinda Gates Foundation, the US Centers for Disease Control and Prevention, GAVI, the Vaccine Alliance and Rotary, are working with national authorities. to strengthen the planning, delivery and monitoring of vaccination campaigns.
"This third round of mass vaccination campaign brings us closer to protecting every child under the age of five across Mozambique from poliovirus. WHO and its partners are working tirelessly in support of the government to end the threat posed by this debilitating disease," said Dr. Severin. von Xylander, WHO Representative in Mozambique.
Beyond vaccination, WHO and its partners have worked to expand two key types of surveillance to detect potential future polio outbreaks in this region: acute flaccid paralysis (AFP) surveillance and environmental surveillance. AFP surveillance aims to detect physical symptoms of polio, including paralysis and mobility problems, while environmental surveillance seeks to find sewage samples that contain traces of polio.
Wild poliovirus transmission remains at an all-time low, with just six cases reported globally in 2021. The importation of any case should be treated as a serious concern and high-quality response efforts to reach all children with the polio vaccine are essential to prevent further spread. .
Wild poliovirus type 1 is currently endemic only in Afghanistan and Pakistan. Poliovirus is highly infectious and mainly affects children under five years of age. The disease can cause lifelong paralysis and can only be prevented through immunization.
International College of Surgeons (ICS) has identified Public Private Partnership (PPP) in the health industry as an evidence-based solution to ameliorate the effect of global pandemic.Dr Ibrahim Wada, Medical Director, Nisa Premier Hospital and Nisa groups, said this at the Annual General Meeting (AGM) of the International College of Surgeons, Nigeria Section, while delivering the 14th Eruchalu Memorial Lecture on Monday in Abuja.In his paper, tagged “The role of Public Private Partnership Value-Chains in Improving Healthcare Services in Nigeria during COVID-19 pandemic,” Wada described the pressure brought by COVID-19 on health system globally as enormous.Wada explained that the PPP arrangements secured the needed cold chains and rapid movement of goods and services to the required places.The partnership, according to him, helped in ameliorating the rapid growth of the pandemic as well as reduction in mortality rates.The theme of the conference is “Global COVID-19 Pandemic: Effects on Safe Surgical Services, Training and Research”.Wada said that through PPP arrangements and collaboration of all and sundry, the nation was able to mitigate the disruptions caused by the pandemic in the system.He identified the disruptions and inadequacies in the country’s health system due to the pandemic to include disruptions at the level of patients, hospital services, supply chains and availability of manufactured goods.Wada defined PPP as a cooperative venture between the public and private sectors, built on the expertise of each partner that best meets clearly-defined needs through the appropriate allocation of resources, risks and rewards.“In the healthcare provider environment, it became rapidly apparent that there were acute shortages of isolation wards and intensive care facilities.“Evidence of PPP which is collaboration emerged quickly whereby philanthropic organisations put up isolation centres and provided Intensive Care Unit (ICU) spaces in support of government efforts to contain the pandemic.“The government provided the lands, policies and license while the private organisations provided funds, buildings, personnel, training and equipment,” he noted.Wada further said that the private sector supported government hospitals to be able to float ICU facilities with Personal Protective Equipment (PPE), facemask, ventilators and volunteer personnel.Wada, who decried the dearth of testing centres in the wake of the pandemic, said the gap resulted in several days of delays to obtain test results, referral and individual apathy.According to him, this gap was also closed through PPP as private testing centres were licensed by the government to complement what it had and this eased testing delays and allowed for quicker diagnosis.“There is no doubt that the licensing of private labs, working in collaboration with government committees, the NCDC and Presidential Task Force on COVID-19, eased the delays in obtaining results and improved treatment outcome for patients.“Also on vaccines production, foreign manufactured vaccines were obtained through COVID-19 Vaccines Global Access, a worldwide initiative aimed at equitable access to vaccines.“This was directed by GAVI vaccine alliance, Coalition for Epidemic Preparedness Innovations (CEPI) and WHO alongside key delivery partner UNICEF”.He added “the critical collaboration aided the unprecedented large-scale distribution of the vaccines among others,” he said.Wada, who frowned at the death of 20 Nigeria Medical Association (NMA) members due to patients affected by the pandemic, blamed the number on inadequate testing and screening.According to him, had the public-private cooperation in the management of the pandemic started early enough, perhaps more lives would have been saved.He, however, called for local production of vaccines as well as medical implements and consumables like PPE, medication and hand gloves.Wada emphasised “this can be best achieved if the government enters into PPP arrangements with relevant manufacturers as quickly as possible.” (
COVID vaccine rights waiver within reach- WTO chief
COVID vaccine rights waiver within reach- WTO chief
Geneva, June 8, 2022 The head of the World Trade Organisation on Wednesday said an international agreement on waiving intellectual property rights for COVID-19 vaccines was within reach, ahead of a global trade meeting.
In a telephone interview, Director-General Ngozi Okonjo-Iweala also said an agreement could be reached on fishing subsidies in time for the meeting, when 120 trade ministers from around the world gather at the body’s Geneva headquarters.
Okonjo-Iweala told Reuters in a telephone interview “if we get one or two deliverables that will be good. I think we are within shouting distance of that.’’
Days before the meeting starts, none of the agreements in the three major negotiating areas of agriculture, fish subsidies or intellectual property rights for vaccines have been finalised for ministers to rubber-stamp, trade sources say.
Instead, Okonjo-Iweala described a “hectic” atmosphere in Geneva where negotiators had been working late nights and weekends in order to try to resolve outstanding differences.
Since she was appointed more than a year ago, Okonjo-Iweala, a former Nigerian minister and chair of the GAVI vaccine alliance board, has prioritised a long-sought deal on a waiver for intellectual property rights for COVID-19 shots.
“There’s some difficult areas we are dealing with but there’s movement,” she said on those talks, without elaborating.
“I think it’s still possible for us to be able to clean that up. Some recent disagreements have centered on the scope of the waiver and China’s objection to some of the agreement’s wording’’ trade sources say.
The WTO’s biennial meeting was twice delayed by COVID-19 and was taking place after a nearly five-year gap against the backdrop of high geopolitical tensions since Russia’s invasion of Ukraine.
Some Western members have refused to negotiate directly with Russia, but Okonjo-Iweala said she was confident negotiations could continue through a combination of different meeting sizes.
“You cannot minimise the Russia-Ukraine tensions and crisis. We find methodologies that work and we will use the same approaches for MC12,” she said, referring to next week’s meeting. (
The Bill and Melinda Gates Foundation has pledged to support Kenya in achieving Universal Health Coverage in addition to continued Covid-19 support.
Speaking during a meeting with the Foundation's Global Development Division, Dr. Christopher Elias, Cabinet Secretary for Health, Mutahi Kagwe, said that Kenya is already working on identifying areas for cooperation in health, especially in establishing Kenya as a pharmaceutical manufacturing hub, as well as in training the health workforce.
He said new areas of collaboration will include expanding human resources for health through training and exchange programs, as well as opportunities to establish drug and vaccine manufacturing plants in Kenya.
“We appreciate the support that the Bill and Melinda Gates Foundation has provided to the country during the pandemic. There is a silver lining in this world, and Covid-19 informed some of the activities we are undertaking at UHC. From importing personal protective equipment for medical workers, we are now exporters of the same, ”said Health CS, noting that the need for local manufacturing for the country and the region has aroused the interest of pharmaceutical giants such as Moderna that plans to establish one of the largest factories outside the US in Kenya.
The CS challenged the Foundation as sponsors to influence their grantees to support local manufacturing of medical products by purchasing from local manufacturers. He noted that the country has moved to promote local manufacturing by extending tax relief through different measures to pharmaceutical manufacturers. In addition, he said that manufacturing efforts will benefit from the creation of logistics centers in the country.
“We will also have the presence of the WHO, which is establishing a logistics center in the country, which means that it will establish a base for support to the region. We hope that the Bill & Melinda Gates Foundation will be instrumental in supporting our efforts to become a pharmaceutical manufacturing hub. We expect GAVI and others to source basic products from local manufacturers,” the CS added.
Speaking during the meeting, the president of the Global Development Division of the Bill and Melinda Gates Foundation said that they are happy to follow the country's path to achieve UHC, adding that the country sets the pace in the region.
“We are pleased to follow the progress made here, including the launch of UHC in February. I am taking the time to learn about other countries and their travels as well. Kenya is an example in the region, and in fact, some of the work that we are doing in other countries, like Ethiopia, is based on our lessons here in Kenya,” said Dr. Elias.
The Bill & Melinda Gates Foundation has been financing several projects in the country through Gavi, the Global Fund and the Global Financing Facility. These projects focus on vaccines, immunization, reproductive health, and now UHC. Other areas of focus are Agriculture with Agra, one of its key partners, based in the country.
Yesterday, the Federal Government of Somalia, the World Health Organization (WHO) and members of the Global Polio Eradication Initiative (GPEI) recommitted to halting the ongoing outbreak of circulating poliovirus type 2 (cVDPV2). in Somalia at a three-day meeting convened in Nairobi. , Kenya. High-level delegates at the meeting included HE Fawziya Abikar Nur, Federal Minister of Health and Human Services, Dr. Mamunur Rahman Malik, WHO Representative in Somalia and Head of Mission, along with high-level representatives from the Bill Foundation. and Melinda Gates (BMGF), the Centers for Disease Control and Prevention (CDC), Rotary International, Save the Children, the United Nations Children's Fund (UNICEF), and other UN agencies and partners.Together, the Government, GPEI partners, including WHO, UNICEF, BMGF, CDC, Rotary International, GAVI, Vaccine Alliance and other key partners, endorsed the Somalia Polio Eradication Action Plan 2022 to reaffirm their commitment.The Somalia Polio Eradication Action Plan 2022 outlines a four-point call to action to stop the spread of the current outbreak, which is one of the longest-running cVDPV2 outbreaks reported to date. The robust plan aims to direct partners' efforts and resources to increase population immunity, making concerted efforts to reach high-risk populations, including nomadic and inaccessible communities and internally displaced persons, to strengthen their immunity, improve the search for poliovirus circulation, and strengthen coordination among all stakeholders. Some of the strategies to be implemented include intensifying efforts to offer 5 polio vaccination opportunities in 2022, providing routine childhood immunization in high-risk locations where children have not received the vaccines, and strengthening community engagement. Given the ease with which the cVDPV2 virus crosses international borders, the emergency plan also calls for greater cross-border coordination between polio eradication programs in Somalia, Kenya, Ethiopia and Djibouti.“In the midst of the ongoing drought, and as they recover from the effects of the COVID-19 pandemic, our stakeholders must not forget how important it is to contain the ongoing poliovirus outbreak so that it does not spread further and does not affect to nobody. more children's lives,” said HE Fawziya Abikar Nur, Federal Minister of Health and Human Services. "On this occasion, I would like to extend my sincere thanks to all of our partners and donors for the immense efforts they have made to protect millions of Somali children from polio over the years."“Since its inception 25 years ago, Somalia's polio eradication program has made progress, including stopping outbreaks of wild poliovirus and, most recently, one of circulating poliovirus type 3 in 2021. The program has established a vast network of human resources and assets against polio and we can do more not only to stop the current outbreak, but also to achieve broader health system goals through the integration and effective use of our human and operational resources. Since 2018, Somalia has carried out several complementary immunization campaigns. Despite these efforts, pockets of children remain unvaccinated due to insecurity and limited access to health services,” said Dr. Mamunur Rahman Malik, WHO Representative in Somalia.The Somalia Polio Eradication Action Plan, to be implemented by 2022, complements one of the goals outlined in GPEI's 'Polio Eradication Strategy 2022-2026: Delivering on a Promise', to stop the transmission of cVDPV and prevent outbreaks in non-endemic countries. It is also in line with Somalia's national goals and the UN Sustainable Development Goals (SDGs).
The Regional Director for Africa of the World Health Organization (WHO), Dr. Matshidiso Moeti, has underlined the Organization's commitment to support Nigeria's efforts to strengthen its health system for better access to adequate health services and quality. Dr. Moeti made the promise during a visit to Africa's most populous country from February 20-25, 2022.
Dr Moeti met with His Excellency President Mohammadu Buhari to discuss stronger collaboration to support Nigeria. Among the issues raised was the need to boost access to vaccines and acceptance of immunization to strengthen the country's capacity to combat vaccine-preventable diseases, such as vaccine-derived poliovirus type 2 (cVDPV2). The delegation that visited the President also reviewed progress towards meeting the indicators in Nigeria's Immunization Accountability Framework.
“I assure you that the Government of Nigeria will continue and improve our work on routine immunization performance; contain outbreaks of circulating vaccine-derived poliovirus, strengthen surveillance against wild poliovirus, and curb the spread of the COVID-19 virus,” said President Buhari.
Dr. Moeti commended Nigeria for maintaining the state budget for primary health care despite the response to COVID-19 and recognized the far-reaching impact of the revitalization of the Center for Primary Health Care (PHC) in provision of health services and community development. She emphasized the importance of an affordable health infrastructure in meeting the needs of access and quality of health in the country.
“I commend the government for ensuring that despite the COVID-19 pandemic, Nigeria has continued the policy of allocating 1% of consolidated revenue funds for primary health care through the Health Care Provision Funds. basic health care, which has the potential to change the narrative in health care financing in Nigeria,” said Dr. Moeti.
“We are committed to supporting the Nigerian government in strengthening its public health system to ensure equitable access to quality health services, including immunization programs that are crucial to safeguarding health and protecting lives. As the most populous nation on the continent, Nigeria has a critical role to play in helping to improve public health standards and practices for Africa,” said Dr. Moeti.
The Regional Director also held initial discussions with the Minister of Finance, Hajiya Zainab Ahmed, the Minister of Health, Dr. Osagie Ehanire, as well as the leadership of the five National Assembly Health committees to advocate for adequate funding for the aimed at strengthening collaboration for health. security and universal health coverage to reduce the incidence of poverty due to illness.
Dr. Moeti also participated in the High Level Mission of the entire GAVI Alliance. He also met with staff from WHO Nigeria, whom he praised for supporting the government in its quest to achieve universal health coverage. He spoke about the ongoing strategic repositioning to align with WHO's transformation agenda.
This mission was Dr. Moeti's fourth in Nigeria and comes as the country has embarked on a mass vaccination campaign against COVID-19 to ensure that at least 70% of the eligible population is fully vaccinated by the end of anus.
President Muhammadu Buhari says steady progress is being made towards achieving the goals set out in the Nigeria Strategy for Immunization and Primary Health Care System Strengthening.
This, he said, follows from preliminary reports showing coverage of the third dose of the pentavalent vaccine increased from 33% in 2017 to 63% in 2019.
The President declared this when he received the Gavi Alliance High Level Mission to Nigeria led by Berkley, Executive Director of the Gavi Alliance and its members, at the State House, Abuja, on Friday.
He said there was a drop to 56 per cent in 2021, due to the impact of the COVID-19 pandemic, adding that "there is much more to be done, however".
According to him, the Federal Government will increase financing to the health sector through the Basic Health Provision Fund and other initiatives.
“Gavi’s disbursement of a total of $1.5 billion in grants to support immunization and health systems strengthening in Nigeria since 2001 has significant results, but I know as partners we would all like to see this happen. translates into an improvement in our health indexes and results. , particularly in the area of maternal and neonatal health.
“Our donors and partners have played their part in providing whatever support is needed to improve our health outcomes.
“Thus, ultimately, the responsibility lies with the Federal and State Ministries of Health, the National Agency for the Development of Primary Health Care and other health care parastatals to focus more on exploring innovative ways to end persistent problems, improve accountability across the board and ensure value for money. prioritized in all health spending,'' he said.
Buhari noted the Gavi Board's exceptional approval for the extension of Nigeria's transition away from Gavi support, which was initially scheduled for 2022 to 2028.
He also highlighted the joint commitment of more than three billion dollars to finance the acquisition of vaccines and interventions to strengthen the health system throughout the country.
“I extend my sincere thanks for the recent support you provided to Nigeria's COVID-19 response efforts through the provision of $762 million in grants, free vaccinations through the COVAX Center, as well as $23 million for the deployment of vaccines,” the president added.
Buhari said he has received regular briefings from the Presidential Steering Committee on COVID-19 and the National Economic Council on ongoing efforts by the Ministry of Health, NPHDA and partners to ensure improved uptake of COVID-19 vaccines.
“Your current strategy of strengthening your engagement and direct support to states is highly commendable and will help improve buy-in at the state and local government level.
“I encourage you to also explore providing support to secondary health care facilities in your engagement with states, as this critical level of our health care system is in dire need of support, particularly in this age of pandemics.
“I assure you that the Government of Nigeria will continue and improve our work on routine immunization performance; contain outbreaks of circulating vaccine-derived poliovirus, strengthen surveillance against wild poliovirus, and curb the spread of the COVID-19 virus,” he said.
The president assured that the federal government will continue to fulfill its financing commitment for routine traditional vaccines and co-financing the introduction of new vaccines in the schedule of the Expanded Program on Immunization of the country.
“We look forward to our continued cooperation with Gavi and other partners in our efforts to achieve the annual targets set out in the Nigeria Strategy for Immunization and Primary Health Care System Strengthening and towards achieving Universal Health Coverage. ”, he added.
In his remarks, the Minister of Health, Dr. Osagie Ehanire, said that the GAVI team was in Nigeria for the annual review of the implementation of the accountability framework for Nigeria's strategy on routine immunization.
While in the country, the team is also expected to support the establishment of a strong primary health care system and access to vaccines.
He added that GAVI had also been very helpful in accessing COVID-19 vaccines through COVAX facilities.
The Executive Director of The Gavi Alliance said that the groundwork for the 2018 Accountability Framework was still being laid the last time he visited the country and that the follow-up visit was an important opportunity to take stock of progress made.
“I am encouraged to report that the Government's commitment to primary health care and immunization remains strong.
"While Covid-19 has set us all back, the ongoing response offers opportunities to strengthen systems to migrate against the resurgence of the virus, as well as the challenges of other vaccine-preventable diseases," he added.
WHO Ethiopia has deployed its core and field staff to support vaccination implementation through direct technical support, supervision and monitoring.ADDIS ABABA, Ethiopia, January 21, 2022/APO Group/ --
A human papillomavirus (HPV) vaccination campaign is underway that aims to immunize more than 1.8 million 14-year-old girls in nine regions against HPV. The campaign started on January 10, 2022 and will end on January 22.
Vaccines were administered in schools and health facilities for two cohorts. More than 866,000 girls aged 14 received the first dose of the vaccine, while 970,000 received the second dose, having received the first dose in January 2021. Two doses of the HPV vaccine are required for complete protection against the virus human papilloma that causes cervical cancer. .
The Ethiopian Pharmaceutical Supply Agency (EPSA) distributed HPV vaccines, vaccination cards and tally sheets to implementing regions. The Ministry of Health and regional health offices have led awareness, social mobilization and communication efforts for the campaign in collaboration with immunization partners.
Prior to the campaign, awareness-raising workshops were held for media professionals, education sector representatives, teachers' associations, immunization partners, and public relations officers from health offices. Staff at the toll-free health hotline call center were also oriented to the vaccine so that they could accurately respond to queries. TV spots are being broadcast on national television, messages are broadcast in regional media and through posters and flyers.
The HPV vaccine was introduced in Ethiopia in December 2018, targeting 14-year-old girls. The Ethiopian Ministry of Health has led the vaccine launch and vaccination delivery in collaboration with regional health offices and the education sector, key stakeholders and immunization partners such as WHO and UNICEF. WHO Ethiopia has deployed its core and field staff to support vaccination implementation through direct technical support, supervision and monitoring.
The vaccines for the campaign were procured and launched with the support of GAVI, the Vaccine Alliance.